id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-318167-b25g6zkp	Einollahi, Behzad	A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma	2020-11-05		.txt	text/plain	1571	80	52	A number of studies reported that CP therapy is also one of the few promising medications for the management of critically ill COVID-19 patients, useful to decrease the viral load, improve the patients clinical outcome, reducing their mortality rate, increasing the probability of extubation and containing the length of hospital stay [9, 10, 11, 12, 13] . In conclusion, emergency therapy with probably CP contributed to heal our critically ill COVID-19 patient, thanks to the antibodies from CP seemingly suppressing the viraemia, which in most viral diseases peaks during the first 7 days since infection [16] . Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Treatment of 5 critically ill patients with COVID-19 with convalescent plasma	./cache/cord-318167-b25g6zkp.txt	./txt/cord-318167-b25g6zkp.txt